51
Participants
Start Date
December 31, 2016
Primary Completion Date
March 31, 2018
Study Completion Date
August 31, 2018
ubenimex
Weill Cornell Medicine, New York
Allegheny General Hospital, Pittsburgh
University of Pennsylvania Medical Center, Pittsburgh
University of Pennsylvania, Philadelphia
Johns Hopkins University, Pulmonary and Critical Care Medicine, Baltimore
Duke University Medical Center, Durham
Cleveland Clinic, Florida, Weston
Vanderbilt University Medical Center, Nashville
Kentuckiana Pulmonary Associates, Louisville
Cleveland Clinic Respiratory Institute, Cleveland
University of Michigan, Ann Arbor
Mayo Clinic College of Medicine, Rochester
Washington University, St Louis
UT Southwestern Medical Center, Dallas
Houston Methodist Hospital, Houston
University Texas Health Science Center, San Antonio
University of Colorado Denver, Aurora
California Heart Center Foundation, An Affiliate of Cedars-Sinai Heart Institute, Cedars-Sinai Medical Care Foundation, Beverly Hills
Harbor - UCLA Medical Center, Torrance
UCSD Medical Center, La Jolla
Stanford University Medical Center, Palo Alto
Chest Medicine Associates, South Portland
Tufts Medical Center, Boston
Brigham and Women's Hospital, Boston
Boston University School of Medicine, Boston
Alpert Medical School of Brown University Rhode Island Hospital, Providence
London Health Sciences Centre, London
University of Ottawa Heart Institute, Ottawa
Lead Sponsor
Eiger BioPharmaceuticals
INDUSTRY